UDK: 615.222

Pharmacoeconomic analysis of efficiency of antiarrhythmic therapy with beta-adrenoblockers in constant form of atrial fibrillation

J. S. Makljakov, V. G. Bitsuev, N. A. Shardanov, O. U. Sokolov, V. V. Horonko

Ростовский государственный медицинский университет, Кардиоцентр Министерства здравоохранения Кабардино-Балкарской Республики

Abstract

Data of pharmacoeconomic analysis of cardioselective beta-adrenoblockers (BAB) are presented, efficiency and safety of metoprolol succinate, nebivolol, bisoprolol for the long control of frequency of atrial contractions (FAC) in patients with constant form of atrial fibrillation (AF) are demonstrated. From pharmacoeconomic point of view bisoprolol can be regarded as a drug of choice among cardioselective beta-adrenoblockers of prolonged action for prolonged therapy of patients with AF.

Keywords

fibrillation of auricles, metoprolol succinate, nebivolol, bisoprolol, pharmacoeconomic analysis, antiarrhythmic therapy.

Contacts

Хоронько Владимир Владиленович — д. б. н., профессор кафедры фармакологии и клинической фармакологии Ростовского государственного медицинского университета, e-mail: kenho@mail.ru